Mersana therapeutics director Anna Protopapas sells shares worth $5,009
Anna Protopapas, a director at Mersana Therapeutics, Inc. (NASDAQ:MRSN), recently sold shares of the company's common stock valued at $5,009. According to a Form 4 filing with the Securities and ...
Mersana Therapeutics SVP sells $2,955 in stock
Alejandra Carvajal, the Senior Vice President and Chief Legal Officer at Mersana Therapeutics, Inc. (NASDAQ:MRSN), recently sold shares of the company’s common stock. The transaction, which took place ...